Category
Category: CAR-T
Immatics Partners GSK in Deal Worth €1B to Develop Cancer Therapies
T-Cell Discovery Could Herald Universal Cancer Immunotherapy
Adaptimmune to Take Off-The-Shelf CAR-T to Phase I with Astellas
BioNTech’s RNA-Boosted CAR T-Cell Therapy Shrinks Tumors in Mice
Cellectis’ Off-the-Shelf CAR T-Cell Therapy Shows Solid Tumor Potential
This Biotech Can Screen CAR T-Cells Using Only Light and Microfluidics
A Cure for Cancer? How CAR T-Cell Therapy is Revolutionizing Oncology
